Cargando…

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia

In recent years, several attempts have been made to identify novel prognostic markers in patients with intermediate-risk acute myeloid leukemia (IR-AML), to implement risk-adapted strategies. The non-receptor tyrosine kinases are proteins involved in regulation of cell growth, adhesion, migration an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallarès, Victor, Hoyos, Montserrat, Chillón, M. Carmen, Barragán, Eva, Prieto Conde, M. Isabel, Llop, Marta, Falgàs, Aïda, Céspedes, María Virtudes, Montesinos, Pau, Nomdedeu, Josep F., Brunet, Salut, Sanz, Miguel Ángel, González-Díaz, Marcos, Sierra, Jorge, Mangues, Ramon, Casanova, Isolda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265715/ https://www.ncbi.nlm.nih.gov/pubmed/30428571 http://dx.doi.org/10.3390/cancers10110436

Ejemplares similares

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients
por: Pallarès, Victor, et al.
Publicado: (2017)

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
por: Falgàs, Aïda, et al.
Publicado: (2020)

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis
por: Moreno, María José, et al.
Publicado: (2018)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
por: Pavón, Miguel Angel, et al.
Publicado: (2016)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
por: Pavón, Miguel Angel, et al.
Publicado: (2015)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
por: Céspedes, María Virtudes, et al.
Publicado: (2018)

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature
por: Díaz-Beyá, Marina, et al.
Publicado: (2015)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models
por: Alamo, Patricia, et al.
Publicado: (2014)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma
por: Téllez-Gabriel, Marta, et al.
Publicado: (2013)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors
por: Mira, Alessia, et al.
Publicado: (2017)

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
por: Díaz-Beyá, M, et al.
Publicado: (2015)

PB2477: INTEGRATION OF OPTICAL GENOME MAPPING IN DAILY CYTOGENETICS LABORATORY ROUTINE.
por: Díaz González, Álvaro, et al.
Publicado: (2023)

Cytogenetic Monitoring of Farmers exposed to pesticides in Colombia.
por: Hoyos, L S, et al.
Publicado: (1996)

Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: Case report
por: Bosch‐Vilaseca, Anna, et al.
Publicado: (2019)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping
por: Díaz-González, Álvaro, et al.
Publicado: (2023)

P986: CYTOGENETIC DIAGNOSIS WITH NEXT-GENERATION CYTOGENETICS BY OPTICAL GENOME MAPPING IN PATIENTS WITH MYELOFIBROSIS.
por: Díaz González, Á., et al.
Publicado: (2022)

“Classical cytogenetics” is not equal to “banding cytogenetics”
por: Liehr, Thomas
Publicado: (2017)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol
por: Fernández, Roger, et al.
Publicado: (2022)

Cytogenetics
por: Swanson, Carl P.
Publicado: (1967)

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients
por: Caramazza, D, et al.
Publicado: (2011)

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
por: Balducci, Estelle, et al.
Publicado: (2022)

IDH1-mutated relapsed or refractory AML: current challenges and future prospects
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic Tumors
por: Nishio, Jun
Publicado: (2011)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

Cytology and cytogenetics.
por: Swanson, Carl P.
Publicado: (1957)

Textbook of cytogenetics
por: Brown, Walter V. (Walter Varian), 1913-
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_7hmd7mm69s95er03994oah6hnn